After enormous public pressure from scientists, dentists, health professionals, and consumers, the U.S. Food and Drug Administration (FDA) promised to make an announcement about dental amalgam by the end of 2011.
Dental amalgam, of course, is composed 50% of the dreadful neurotoxin mercury.
Jeffrey Shuren, director of the Center for Devices and Radiological Health (CDRH, the branch of the FDA responsible for the approval and safety of all medical devises) said at a public hearing in September, in San Francisco, that FDA will make an “announcement” on a new amalgam policy by the end of 2011.
When questioned by a reporter at a major newspaper, FDA repeated that it would act in 2011.
As 2011 came to a close, the suspense grew as everyone speculated whether FDA would act or whether it would continue its decades of protecting the profits of pro-mercury dentists instead of protecting the health of American children.